Status:
COMPLETED
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hodgkin's Lymphoma
Leukemia
Eligibility:
All Genders
18-74 years
Phase:
NA
Brief Summary
The goal of this project is to refine and evaluate the feasibility of a brief, behavioral intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients...
Detailed Description
Details of the assessment strategy: Patient-reported outcomes: Participants will complete self-report measures prior to HSCT and 9 (mid-intervention) and 18 weeks (post-intervention) post-HSCT. The ...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older undergoing hematopoietic stem cell transplantation (HSCT) at the University of Wisconsin Carbone Cancer Center (UWCCC)
- Autologous transplant recipients with multiple myeloma or lymphoma (both Hodgkin's and Non-Hodgkin's types) receiving standard conditioning regimens
- Allogeneic transplant recipients undergoing fully ablative transplants
- Participants who develop treatment complications or disease recurrence after being enrolled in the study may continue to participate if they are able to do so
Exclusion
- Autologous transplant recipients receiving non-standard regimens
- Autologous transplant recipients with diagnoses other than multiple myeloma or lymphoma
- Allogeneic transplant recipients receiving reduced intensity regimens
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2017
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02719821
Start Date
March 1 2016
End Date
June 2 2017
Last Update
November 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States, 53792